Third Quarterly results for December 2007 declared in the month of January 2008
Company | 2007 | 2006 | Percentage |
Aurobindo Pharma | Rs 5,494.20 million | Rs 5,547.30 million | 0.95% decrease |
Cadila Healthcare | Rs 4,539 million | Rs 3,544 million | 18.67% increase |
Divis Laboratories | Rs 2,887.30 million | Rs 1,520.70 million | 89.86% increase |
Dr Reddys Laboratories | Rs 625.50 million | Rs 1,056.30 million | 40.78% decrease |
JB Chemicals & Pharmaceuticals | Rs 1,470.89 million | Rs 1,374.50 million | 7.01% increase |
Merck | Rs 904.39 million | Rs 796.80 million | 13.50% increase |
Novartis India | Rs 224.7 million | Rs 210.7 million | 6.64% increase |
Sun Pharmaceutical | Rs 9,603.30 million | Rs 6,127.00 million | 56.74% increase |
Torrent Pharmaceuticals | Rs 372.70 million | Rs 256.50 million | 45.30% increase |
Wanbury | Rs 567.9 million | Rs 357.5 million | 59% increase |
Zydus Cadila | Rs 57.96 million | Rs 47.24 million | 22.7% increase |